.jpg)
.png)
Summer 2016
This issue sponsored by the Northeast Lipid Association Featuring: "The Continuing Saga of HDL: Truth, Fallacy, or Something in Between?" and "Nutrition Recommendations and Disorders of Lipid Metabolism: Untangling the Confusion among Consumers and Healthcare Providers" more
William Hazlitt, an 18th century literary critic and philosopher, once said, “When a thing ceases to be a subject of controversy, it ceases to be a subject of interest.”1 If one accepts his premise, then interest in high-density lipoprotein (HDL) shall endure for some time. As far as contemporary... more
Cardiovascular disease (CVD) is the leading cause of death in the U.S.1 There have been many important advances in the treatment of CVD in recent decades. However, not all touted therapies carry the same quality of evidence supporting their use. Chelation therapy is one such treatment that has been... more
Coconut oil consumption is rapidly increasing. This increase is in part because of supposed health benefits, including relieving mental fatigue and depression, altering risk factors of cardiovascular disease, and modifying cognition.1 Despite limited evidence for these purported benefits,... more
“He who thinks he knows, doesn’t know. He who knows that he doesn’t know, knows. For in this context, to know is not to know. And not to know is to know.” – Joseph Campbell, The Power of Myth I provide printed instructions to my patients after office visits that read: “As we discussed, you have... more
Wenliang Song, MD, is a third-year internal medicine resident at Bridgeport Hospital of Yale University. He has been a very active young member of the National Lipid Association (NLA). He is on the NELA Membership Committee and the Early Career Development Committee. Dr. Song recently took the... more
As we approach the half year mark of 2016, we are reminded once again of the tremendous support surrounding the Foundation of the NLA and its mission to reduce cardiovascular events and deaths through patient and clinician education. To help reach our goals, the Foundation is constantly finding new... more
As I near the end of my term as president of the National Lipid Association (NLA), I have so many thoughts about this rewarding experience that I want to share with you. I remember meeting with an ever-smiling Michael Davidson, MD, FNLA, in 2004, who had so much to tell me about this young... more
Welcome to the Scientific Sessions issue of the LipidSpin — this year sponsored by the Northeast Lipid Association (NELA). We have had a lot of fun putting this issue together, and hope that you will enjoy reading this issue just as much. The theme for this issue is “Debunking Common Myths in... more
The global epidemic of type 2 diabetes (T2DM) continues unabated. Atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are the most common causes of T2DM-related mortality. More than 90 percent of patients with T2DM are overweight or obese. The pathogenesis of this disorder is... more